| Literature DB >> 31013693 |
Seok Kyeong Oh1, Woo-Keun Kwon2, Sangwoo Park3, Sul Gi Ji4, Joo Han Kim5, Youn-Kwan Park6, Shin Young Lee7, Byung Gun Lim8.
Abstract
We aimed to investigate operating conditions, postoperative pain, and overall satisfaction of surgeons using deep neuromuscular blockade (NMB) vs. no NMB in patients undergoing lumbar spinal surgery under general anesthesia. Eighty-three patients undergoing lumbar fusion were randomly assigned to receive deep NMB (n = 43) or no NMB (n = 40). In the deep-NMB group, rocuronium was administered to maintain deep NMB (train-of-four count 0, post-tetanic count 1-2) until the end of surgery. In the no-NMB group, sugammadex 4 mg/kg at train-of-four (TOF) count 0-1 or sugammadex 2 mg/kg at TOF count ≥2 was administered to reverse the NMB 10 min after placing the patient prone. Peak inspiratory airway pressure, plateau airway pressure, lumbar retractor pressure significantly were lower in the deep-NMB group. Degree of surgical field bleeding (0-5), muscle tone (1-3), and satisfaction (1-10) rated by the surgeon were all superior in the deep-NMB group. Pain scores, rescue fentanyl consumption in post-anesthesia care unit (PACU), and postoperative patient-controlled analgesia consumption were significantly lower in the deep-NMB group, and this group had a shorter length of stay in PACU. Compared to no NMB, deep NMB provides better operating conditions, reduced postoperative pain and higher overall satisfaction in lumbar spinal surgery.Entities:
Keywords: neuromuscular blockade; neuromuscular monitoring; neurosurgical procedures
Year: 2019 PMID: 31013693 PMCID: PMC6518127 DOI: 10.3390/jcm8040498
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure A1Neuromuscular monitoring with a wrist brace. (A) The forearm was immobilized with a detachable wrist brace (Neoban wrist support, Seoul Brace, Seoul, Korea) that allowed the thumb to move, (B) with the stimulating electrode attached to the passage of the ulnar nerve and the elastic preload positioned at the thumb to monitor the response of the adductor pollicis.
Figure A2The patient positioning and the study setup including the screen setup for masking groups from surgeons.
Figure 1The pressure transducer used for retractor pressure monitoring was attached to a retractor blade. It was mounted on the middle of the inner surface of the retractor. (a) Medial view. (b) Lateral view.
Figure A3The retractor pressure transducer setting. (A) A flat planar pneumatic pressure transducer was placed beneath the lumbar retractor blade (B) then the lumbar retractor blades were retracted until they reached the lateral margin of the bilateral facet joints, and (C) the value of the back muscle retractor pressure (mmHg) was shown via a pressure monitor (red circle).
Figure 2A flow-chart describing patient recruitment, randomization, and withdrawal. NMB: neuromuscular blockade.
Patient characteristics and clinical data.
| Deep NMB | No NMB | |
|---|---|---|
| ( | ( | |
| Age (year) | 61 (37–75) | 60 (30–75) |
| Sex (male/female) | 12/31 | 11/29 |
| ASA (I/II) | 11/32 | 7/33 |
| Height (m) | 1.59 ± 0.07 | 1.58 ± 0.08 |
| Weight (kg) | 59.8 ± 8.5 | 60.0 ± 6.9 |
| Operation level (1/2) | 36/7 | 36/4 |
| Operation time (min) | 221.9 ± 48.6 | 220.7 ± 51.3 |
| Anesthesia time (min) | 263.6 ± 53.6 | 257.6 ± 53.2 |
Values are mean ± standard deviation, median (range) or number of patients; NMB, neuromuscular blockade; ASA, American Society of Anesthesiologists physical status classification.
Intraoperative outcomes including airway pressures and variables measured for operating condition assessment, and cumulative dose of rocuronium and average infusion rate of anesthetics.
| Deep NMB | No NMB | ||
|---|---|---|---|
| ( | ( | ||
| Variables for operating condition | |||
| Peak inspiratory airway pressure (cmH2O) | 18.4 ± 1.1 | 20.2 ± 1.1 | <0.001 |
| Plateau airway pressure (cmH2O) | 17.1 ± 1.4 | 19.4 ± 1.1 | <0.001 |
| Retractor pressure (mmHg) | 81.2 ± 9.1 | 100.0 ± 7.3 | <0.001 |
| Surgical field bleeding scale (0/1/2/3/4/5) | 0/14/23/5/1/0 | 0/1/4/19/16/0 | <0.001 |
| Retractor placement muscle tone (1/2/3) | 29/8/6 | 0/4/36 | <0.001 |
| Screw insertion muscle tone (1/2/3) | 37/1/5 | 5/10/25 | <0.001 |
| Other muscle tone (1/2/3) | 31/12/0 | 4/26/10 | <0.001 |
| Body movements (number per patient) | 0 (0–0) | 2 (0–4) | <0.001 |
| Surgical satisfaction (1–10) | 8.0 ± 1.3 | 3.1 ± 1.2 | <0.001 |
| Administered dose of drugs | |||
| Total rocuronium (mg) | 232.4 ± 71.5 | 75.4 ± 13.2 | <0.001 |
| Induction rocuronium (mg) | 59.9 ± 8.3 | 60.0 ± 6.9 | 0.571 |
| Rescue rocuronium (mg) | 0 (0–5) | 15 (0–35) | <0.001 |
| Remifentanil average rate (μg kg−1 min−1) | 0.035 ± 0.017 | 0.041 ± 0.020 | 0.167 |
| Propofol average rate (mg kg−1 min−1) | 0.104 ± 0.014 | 0.113 ± 0.015 | <0.001 |
Values are mean ± standard deviation, median (range) or number of patients; Surgical field bleeding scale: 0—No bleeding, 1—Slight bleeding—no suctioning of blood required, 2—Slight bleeding—occasional suctioning required, 3—Slight bleeding—frequent suctioning of blood was required but not threatened the operative field, 4—Moderate bleeding—frequent suctioning of blood was required which moderately threatened the operative field, 5—Severe bleeding—very frequent suctioning of blood was required which severely threatened the operative field; NMB, neuromuscular blockade.
Figure 3The change over time in (a) train-of-four (TOF) ratio, (b) bispectral index (BIS), (c) mean arterial pressure and (d) heart rate at the main time points during the perioperative period. NMB: neuromuscular blockade. The graphs show the mean value and standard deviation of each variable for each time point during general anesthesia. Time point 1: at baseline (before anesthesia), 2: at intubation, 3: at skin incision, 4: 30 min after skin incision, 5: 60 min after skin incision, 6: 120 min after skin incision, 7: at the end of surgery. * p < 0.001.
Postoperative outcomes in the operating room, post-anesthesia care unit (PACU) and ward.
| Deep NMB ( | No NMB ( | ||
|---|---|---|---|
| Operating room | |||
| Time to the recovery of spontaneous respiration (min) | 5.4 ± 3.8 | 6.1 ± 4.3 | 0.623 |
| Time to the recovery of eye opening (min) | 8.3 ± 4.3 | 8.9 ± 4.3 | 0.509 |
| Time to extubation (min) | 10.1 ± 3.9 | 10.7 ± 4.5 | 0.795 |
| PACU | |||
| Numeric rating scale for pain (0–10) | 0.010 | ||
| when arriving at PACU | 6.2 ± 2.0 | 8.4 ± 0.6 | |
| 30 min after arriving at PACU | 3.9 ± 1.9 | 6.9 ± 0.9 | |
| 60 min after arriving at PACU | 2.5 ± 1.4 | 5.1 ± 1.4 | |
| Recovery time (time to sedation score 5) (min) | 10.5 ± 7.9 | 17.0 ± 11.4 | 0.060 |
| Length of stay (min) | 61.9 ± 5.9 | 87.0 ± 24.5 | <0.001 |
| Rescue fentanyl consumption (μg) | 31.4 ± 24.4 | 86.3 ± 29.9 | <0.001 |
| Adverse events (Y/N) | 0/43 | 8/32 | 0.002 |
| Ward | |||
| Numeric rating scale for pain (0–10) | 0.087 | ||
| 6 h after operation | 3.1 ± 1.1 | 3.5 ± 0.8 | |
| 24 h after operation | 2.3 ± 1.2 | 2.3 ± 0.8 | |
| 48 h after operation | 1.3 ± 0.7 | 1.8 ± 0.9 | |
| Total PCA consumption (mL) | 39.9 ± 11.9 | 51.2 ± 9.3 | <0.001 |
| Postoperative nausea or vomiting | 1/9/1/32 | 4/4/0/32 | 0.202 |
| Other adverse events (Y/N) | 0/43 | 4/36 | 0.050 |
Values are mean ± standard deviation or number of patients; Adverse events at PACU in the no-NMB group: hypertension 4, hypotension 4. Other adverse events at Ward in the no-NMB group: dizziness 4; NMB: neuromuscular blockade; PACU, post-anesthesia care unit; PCA, patient-controlled analgesia.